rGO Copolymer Nanocarriers for Soluble Targeted Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Reduced graphene oxide (rGO) suffers from low water solubility and biocompatibility issues, limiting its use as a drug carrier, and existing surface coatings like PEG do not allow further modification, complicating its application in drug delivery.
Innovation Solution
A modular nanocarrier system is developed by coating rGO with a PAMP-graft-PHDT copolymer, utilizing π-π interactions and click reactions to attach cargo molecules, providing biocompatibility and enabling targeted drug delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If rGO is used as a drug carrier, then toxicity is reduced compared to graphene, but water solubility and biocompatibility remain low
Solution Approach 1:
The patent introduces a copolymer coating as an intermediary layer between the rGO surface and the biological environment. This copolymer coating serves as a mediator that improves water solubility and biocompatibility while maintaining the underlying rGO structure and its drug-carrying capability.
Solution Approach 2:
The patent creates a composite material system by combining rGO with a copolymer coating. This composite structure integrates the low toxicity advantage of rGO with the improved solubility and biocompatibility properties of the copolymer coating, achieving a balanced material for drug delivery applications.
2Reliability
If PEG is used to coat rGO surface, then bioavailability is increased, but further modification becomes impossible
Solution Approach 1:
The patent segments the coating structure into multiple functional layers: an inner copolymer layer that provides biocompatibility and solubility, and an outer modular component that enables further modification. This segmentation allows each layer to perform its specific function independently while maintaining overall system versatility.
Solution Approach 2:
The patent introduces dynamic modularity to the coating structure, allowing the outer layer to be adjusted or modified based on specific application requirements. This dynamic design enables the system to adapt to different drug types and delivery requirements while maintaining the core biocompatibility functions.
3Stability of the object's composition
If oxygen groups are decreased on GO structure, then surface formation becomes perfect, but solubility partially decreases
Solution Approach 1:
The patent applies parameter changes by carefully controlling the degree of reduction of oxygen groups on the graphene oxide structure. By optimizing this parameter, the system achieves improved surface formation quality while maintaining sufficient solubility through the combined effect of the modified graphene structure and the copolymer coating.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PAMP-graft-PHDT coated rGO nanocarriers enhance bioavailability and facilitate targeted drug release, demonstrating improved biocompatibility and efficacy in cancer treatment.
Implementation Method 1
utilizing π-π interactions and click reactions to attach cargo molecules
Data Source
AI summary
The present invention is related to reduced graphene oxide (rGO) nanoplatforms coated with a methacrylate-based copolymer and the methods used in the preparation of these platforms for use as a drug carrier system.